Braslyn Ltd., 10% Owner at Mirati Therapeutics, Inc. (MRTX), sold 600,006 shares at $97.00 ($58.2M) on 2020-06-12, disclosed to the SEC on 2020-06-16.
Open-market sale of $58.2M MRTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $97.00 | 600,000 | $58.2M | 100.0% |
| 2 | $100.69 | 6 | $604 | 0.0% |
| Total | $97.00 avg | 600,006 | $58.2M | 100% |
| Filing → |
| MRTX | SELL | 2019-03-05 | $19.0M | — | Filing → |
| MRTX | BUY | 2017-11-20 | $5.2M | — | Filing → |
| MRTX | BUY | 2017-01-30 | $525K | — | Filing → |